About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
City of Hope
www.cityofhope.org
Breast
Lung
Gastrointestinal
Genitourinary
Leukemia
Lymphoma
Myeloma
Hematologic Malignancies
Head and Neck
General Oncology
Palliative Care
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
E
2020 SOHO Update on CAR-T for R/R AML: What Are the Current Limitations? How Can We Improve the Efficacy and Safety?
By
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
FEATURING
Elizabeth Budde
By
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
FEATURING
Elizabeth Budde
26 views
December 11, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Leukemia
08:26
City of Hope
Primary Analysis of TRANSCEND CLL 004 - Liso-Cel in R/R CLL/SLL
Feat.
T. Siddiqi
08:35
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Primary Analysis of the Phase 1/2, Single-Arm, Multicenter…
Feat.
T. Siddiqi
06:23
City of Hope
TKI-BiTE Combo in Ph+ALL: Integrating Expert Opinion With Clinical T…
Feat.
I. Aldoss
06:57
ASH 2022 Conference Coverage
ASH 2022 NX-2127-001, a First-in-Human Trial of NX-2127, a BTK-Targe…
Feat.
A. Danilov
06:20
ASH 2022 Conference Coverage
Consolidation With Allogeneic HCT Improved Survival Outcomes of Adul…
Feat.
I. Aldoss
09:33
City of Hope
Assessing Comorbidities in CLL
Feat.
A. Danilov
18:28
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on Optimizing Lymphodepletion Prior to CAR-T Therap…
Feat.
E. Budde
33:39
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on CAR-T for R/R AML: What Are the Current Limitati…
Feat.
E. Budde
25:04
City of Hope
How to Sequence Novel Agents in CLL
Feat.
T. Siddiqi